The Hessian research funding program LOEWE is supporting two DZL projects with more than four million euros. Funding will go to a project which focuses on the relevance of lipids in the development of diseases,...
Despite their enormous disease burden, respiratory illnesses such as COPD and asthma receive little attention in research, policy, and public discourse. An international group of early career scientists is now calling for greater visibility, national...
Dr. Andrew Tony-Odigie, a scientist at the DZL Academy based at TLRC, has been awarded the Adolf Windorfer Prize 2025 together with his team. The research group demonstrated how beneficial bacteria can inhibit the growth...
Prof. Dr. Dr. med. Susanne Herold, a renowned lung and infection researcher from Giessen and DZL scientist, has been elected to the prestigious Leopoldina – German National Academy of Sciences. The Leopoldina, founded in 1652,...
A new study by DZL-scientists reveals how cancer-associated fibroblasts (CAFs), a key component of the tumor microenvironment, enable lung tumors to resist targeted therapies by rewiring cellular metabolism.
Which analysis tools deliver reliable results in single-cell research? The open-source initiative Open Problems, coordinated in part by DZL researchers, establishes the first comparable standards—making AI-driven research across disciplines more accessible and transparent.
From June 30 to July 2, 2025, the DZL community gathered at the Heidelberg site TLRC for the 13th DZL Annual Meeting. With around 730 participants and the largest poster session in DZL history, the...
How can drug levels be measured directly in the lung—completely non-invasively? A new study led by DZL researchers Prof. Jens Hohlfeld and Dr. Olaf Holz from Fraunhofer ITEM provides an answer.
The Cardio-Pulmonary Institute (CPI) is among the selected Clusters of Excellence in the current funding line of the German Research Foundation (DFG) and will receive funding for another seven years. Out of 98 applications, the...
In the current funding round of the Excellence Strategy, the German Research Foundation (DFG) has selected three excellence clusters involving scientists from the DZL. Out of 98 submitted proposals, these clusters were successful and will...
A better understanding of their condition can be crucial for the long-term treatment success of patients with Chronic Obstructive Pulmonary disease (COPD).
Modern health research aims to understand disease patterns so comprehensively that the earliest possible differentiated and personalised prevention can be realised. The latest edition of SYNERGIE explores the research methods employed by the German Centres...
